Table 2.
Study | Subjects | Sample and Techniques | Microbiota Alterations | Other Findings |
---|---|---|---|---|
El Mouzan et al. [46] | 20 CD children 20 fecal controls 19 mucosal controls |
Duodenal samples of CD ↑Pseudomonadota phylum ↑Lactobacillus acidophilus, Neisseria spp. ↑Coprococcus spp. Fecal samples of CD ↑Verucomicrobia spp. ↑Clostridium spp. ↑Escherichia spp. ↑Lachnospiraceae_bacterium_oral ↓Bifidobacterium genus ↓Bacteroides spp. |
Fecal samples were more diverse and richer in bacteria compared with mucosal samples Bacillota and Bacteroidota were the most abundant phyla in both fecal and mucosal samples |
|
Zafeiropoulou et al. [47] | 20 CD children 45 CD under GFD 57 healthy controls 19 children at risk of CD |
Fecal sample 16S rRNA sequencing | Untreated CD ↓Clostridium sensu stricto 1 genus ↓Ruminococcus genus |
Microbial dysbiosis was not reported in CD compared to healthy controls Alistipes was correlated with the presence of symptoms of CD |
Di Base et al. [50] | 21 CD children 16 healthy controls |
Fecal samples Duodenal sample 16S rRNA sequencing |
Duodenal samples of CD ↑Enterobacteriaceae family ↑Bacteroidetes/Streptococcus spp. Fecal samples of CD ↓ Bacteroides–Prevotella ↓Akkermansia spp. ↓Staphylococcaceae family |
Patients with abdominal pain ↑Bacillaceae family ↑Enterobaeriaceae family Patients with diarrhea ↓Clostridium cluster XIVa ↓Akkermansia ↑Bacillaceae ↑Fusobacterium |
Schippa et al. [62] | 20 CD children, before and after GFD 10 healthy controls |
Duodenal sample 16S ribosomal DNA analysis compared with TTGE | In CD patients vs. controls ↑Bacteroides vulgatus ↑Escherichia coli Active CD vs. Inactive CD prevalence B. vulgatus (80% vs. 90%) Clostridium coccoides group (50% vs. 90%) Bifidobacterium spp (20% vs. 40%) |
Mean interindividual similarity index: 54.9% ± 14.9% Active CD 55.6% ± 15.7% remission state 21.8% ± 30.16% controls Similarity index between CD children before and after GFD: 63.9% ± 15.8% |
Sample et al. [63] | 22 CD children, before and after GFD 17 healthy controls |
Fecal sample16S ribosomal RNA sequencing | Active CD vs. Controls ↑Haemophilus genera ↑Alistipes genera ↑Bacteroides genera |
|
El Mouzan et al. [51] | 40 CD children 39 controls |
Fecal samples Duodenal sample metagenomic analysis of microbial DNA |
Fecal samples of CD ↓Bacteroides intestinalis ↓Burkholderiales bacterium 1-1-47 Mucosal samples of CD ↓Human_endogenous_retrovirus_K) |
|
El Mouzan et al. [61] | 40 CD children 39 controls |
Fecal samples Duodenal sample metagenomic analysis of microbial DNA |
Fecal samples ↑ Human polyomavirus 2, Enterobacteria phage mEpX1, Enterobacteria phage mEpX2 |
Mucosal samples—no association with CD |
El Mouzan et al. [55] | 40 CD children 39 controls |
Fecal samples Duodenal sample metagenomic analysis of microbial DNA |
Fecal samples of CD ↓Pichiaceae family ↓Pichia kudriavzevii ↑Saccharomycetes family ↑Saccharomyces cerevisiae ↑Tricholomataceae family ↑Mucosal samples of CD ↑ Saccharomycetaceae family ↑Candida spp. ↓Pneumocystis spp. ↓Pneumocystis jirovecii |
Fecal fungal communities were more abundant than those observed in mucosal samples |
Sanchez et al. [64] | 32 active CD on GFD 17 8 healthy controls |
Duodenal mucosa sample 16S ribosomal RNA sequencing | Active CD ↑Pseudomonadota phylum ↑Enterobacteriaceae family ↑Klebsiella oxytoca ↑Staphylococcus epidermidis ↑Staphylococcus pasteuri ↓Bacillota phylum ↓Streptococcaceae family |
Non-active CD ↑Streptococcus mitis group |
TTGE—temporal temperature gradient gel electrophoresis; ↑ increased levels; ↓decreased levels.